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Introduction
The basic chemical structure of nucleic acids (e.g. , deoxyribo-
nucleic acid, DNA, and ribonucleic acid, RNA) is common and
independent of the taxonomic rank, for all living and extinct
species in the biosphere. Nucleic acids consist of canonical nu-
cleosides interlinked with phosphodiester bonds to form
higher-order helical and other topology structures.[1, 2] Nucleo-
side units are built of five canonical nucleobases (adenine, gua-
nine, thymine cytosine and uracil) which are attached to the
anomeric C atoms of d-deoxyribofuranose (in DNA) and d-ribo-
furanose (in RNA) sugars, respectively. Furthermore, the nu-
cleosides can contain noncanonical (epigenetic) modified nu-
cleobases. Although the biological function of such modified
nucleobases is still far from being fully understood, it is appar-
ent that they play crucial roles, for example, in gene expression
and in gene silencing.[3] In contrast, modified nucleosides and
their components have been in the focus of chemical studies
for decades.[4] As a result, many modified nucleosides have
found therapeutic applications, mainly as antiviral and anti-
cancer drugs.[5, 6]
Xeno-nucleic acid (XNA) chemistry is aimed at developing
and investigating entirely new classes of artificial nucleic acids
that have the ability to carry genetic information, undergo mo-
lecular evolution, and serve as tools for molecular biology
studies.[7–9] XNA chemistry also sheds light on prebiotic chemis-
try and the origin of life on planet Earth. Formally, the term
XNA denotes a nucleic acid that does not exist in the living
world and whose d-(deoxy)ribofuranose backbone is replaced
by an alternative sugar or nonsugar moiety.[7] According to the
above definition, progress in XNA chemistry relies on the de-
velopment of new artificial nucleoside building blocks.
Until recently, there have been two separate families of XNA
nucleosides described in the literature. The first major group
consists of purely organic molecules, whereas the second, of
fewer examples, consists of organometallic ferrocenyl com-
pounds. A simplified “phylogenetic-like tree” showing both
classes of nucleosides is presented in Figure 1.
The arrows in Figure 1 tentatively represent gradual structur-
al changes on going from the glycol nucleic acid (GNA) nucleo-
side,[10–13] followed by flexible nucleic acid (FNA) nucleo-
sides[14, 15] through canonical thymidine nucleosides and finally
to their more structurally distant congeners such as arabino
nucleic acid (ANA),[16] 2’-fluoro-arabino nucleic acid (FANA),[17]
and a-l-threofuranose nucleic acid (TNA)[18] nucleosides.
Branches consist of aminopropyl nucleic acid (APNA) nucleo-
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cene/ferrocenium reference redox couple.
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sides,[19] d-threoninol nucleosides,[20] isonucleosides (INA)[21]
and locked nucleic acid (LNA) nucleosides.[22] Branched from
DNA are the homo-DNA,[23] hexitol nucleic acid (HNA),[24] cyclo-
hexene nucleic acid (CeNA)[25] and morpholino nucleic acid nu-
cleosides.[26] Remarkably different from all the above purely or-
ganic nucleosides are compounds containing the ferrocenyl
moiety. Members of this family are organized into a separate
branch on the phylogenetic-like tree in Figure 1. Ferrocene
itself is a redox-active, aromatic organometallic molecule with a
characteristic 3D sandwich-type structure. Ferrocenyl derivatives
have found a plethora of applications in catalysis,[27] material
sciences,[28] as well as in biology and medicinal chemistry.[29–31]
The rationale for the introduction of the ferrocenyl group
into the nucleoside skeleton is well justified by the expectation
of obtaining new classes of genetic information carriers having
additional redox-active properties. Furthermore, it has been re-
ported that some planar chiral ferrocenyl nucleosides show cy-
totoxic activity against human cancer cells with IC50 values in
the low micromolar concentration range.[32,33] There are two
general strategies toward the synthesis of ferrocenyl nucleic
acids. The first relies on chemical or enzymatic oligomeriza-
tion/incorporation of ferrocenyl nucleosides into the biopoly-
mer and the second uses postsynthetic incorporation of ferro-
cenyl moieties into oligonucleotide strands. These strategies
have been discussed in an excellent review.[34] The develop-
ment of ferrocenyl XNA nucleosides and nucleic acids is a hot
topic in chemistry.
The first ferrocenyl nucleoside FcNA1 (Figure 1) was reported
in 2012 by Tucker and co-workers.[35] Following the challenging
multi-step synthesis, FcNA1 was successfully polymerized on a
nucleic acid synthesizer to afford the first ever ferrocenyl nu-
cleic acid oligomers.[35] The oligomer was soluble in aqueous
phosphate buffer at physiological pH, similar to natural nucleic
acids. Cyclic voltammetry (CV) was used to study the redox
processes of the FcNA1 oligomer.[35] The resulting cyclic vol-
tammogram showed a quasi-reversible wave centered at
212 mV versus a Ag/AgCl reference, which originates from the
oxidation–reduction of the ferrocenyl backbone moiety.
Recently, our group reported on the synthesis of the ferro-
cenyl nucleoside FcNA2 (Figure 1), which is the second known
representative of ferrocenyl nucleosides.[36] Compound FcNA2
shares important common structural features with FcNA1, per-
taining to the replacement of the d-ribofuranose backbone of
canonical nucleoside by the 1,1’-disubstituted ferrocenyl
moiety. Such a replacement forces the ferrocenyl group to be
in the backbone of the nucleic acid strand. Until now, FcNA1
and FcNA2 remain unrelated to the rest of the XNA nucleoside
family shown in Figure 1.
Figure 1. Simplified phylogenetic-like tree for XNA nucleosides shown with thymine as an exemplary nucleobase. The transition from organic to ferrocenyl nu-
cleosides is marked by red arrows. Green arrows denote relatively close structural relationships between nucleosides, and black arrows pertain to more distant
structural similarities.
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Herein, we report on the enantioselective synthesis, electro-
chemistry and DFT calculations of the ferrocenyl glycol nucleic
acid (Fc–GNA) nucleosides (S,R)-1 and (R,S)-1 and their methy-
lated derivatives (S,R)-2 and (R,S)-2 (Scheme 1). Furthermore,
methylated derivatives were studied with X-ray diffraction and
circular dichroism (CD) spectroscopy. The discussed nucleo-
sides are close relatives to quasi-nucleoside A (Figure 1),[37] nu-
cleoside FcNA2[36] and, most importantly, to metal-free GNA
nucleosides.[10–13] Therefore, compounds (S,R)-1 and (R,S)-1
could be considered as “missing links”, bridging the purely or-
ganic XNA nucleosides with organometallic ones.
Results and Discussion
Synthesis
GNA nucleosides are characterized by a single stereogenic
carbon atom center in their molecular structure.[10–13] In con-
trast to that, the Fc–GNA derivatives studied herein possess
two vicinal stereogenic carbon atom centers. Therefore, the
synthesis of the enantiomerically pure Fc–GNA nucleosides re-
quires either a separation of racemic mixtures or the synthesis
of pure enantiomers. In the course of our work, we decided to
utilize the latter approach. The synthetic methodology for the
nucleosides (S,R)-1 and (R,S)-1, their methylated derivatives
(S,R)-2 and (R,S)-2 is summarized in Scheme 1.
The synthesis starts with alcohol A, which was prepared ac-
cording to a previous report.[37] In the next step, dehydration
of compound A was achieved by its treatment with ytterbiu-
m(III) trifluoromethanesulfonate in ethylene glycol at 110 8C.
This reaction afforded [3-(N1-thyminyl)-1-(ferrocenyl)]prope-
ne (B)[37] in 66% yield. Notably, the reported literature method
for the synthesis of B was less effective and gave B in only
32% yield.[37] Alkene B was then utilized as a substrate for the
preparation of the chiral a,b-dihydroxy (S,R)-1 and (R,S)-1 iso-
mers. To achieve this goal, a Sharpless catalytic asymmetric di-
hydroxylation was applied.[38] As a starting point in the search
for the most suitable reaction conditions, we used the results
of asymmetric dihydroxylation reactions conducted on relative-
ly simple substrates such as vinylferrocene and homoallylferro-
cene.[39] Based on these initial data, we were able to develop
suitable reaction conditions for the asymmetric hydroxylation
of substrate B. Accordingly, treatment of B with 3 equivalents
of K3Fe(CN)6 and K2CO3, 4 mol% K2OsO2(OH)4 and 10 mol%
hydroquinidine-2,5-diphenyl-4,6-pyrimidinediyl diether
[(DHQD)2Pyr] in a water/acetonitrile solvent mixture at ambient
temperature for 3 h afforded nucleoside (S,R)-1 in 72% yield
and >99% ee. Using the same reaction conditions, but
with hydroquinine 2,5-diphenyl-4,6-pyrimidinediyl diether
[(DHQ)2Pyr] as a ligand, allowed the isolation of a (R,S)-1
isomer in 70% yield and in 71 ee. Nucleosides (S,R)-1 and (R,S)-
1 are air-stable, yellow crystalline solids. They were character-
ized by spectroscopic methods, including 1H NMR, 13C NMR
and IR spectroscopy, mass spectrometry, and elemental analy-
sis. To assign the absolute configurations at the stereogenic
centers in both products, we attempted to obtain X-ray-quality
single crystals. However, these attempts failed. Therefore, the
nucleosides were transformed into their methylated derivatives
according to a literature method.[36] This procedure comprises
the reaction of either nucleoside with NaH and MeI (Scheme 1)
which does not influence stereochemical configuration. As a
consequence, the absolute configuration at the stereogenic
centers was retained. The respective methylation reaction af-
forded compounds (S,R)-2 and (R,S)-2 as yellow crystalline
solids in approximately 30% yield. These compounds were
characterized by spectroscopic methods, mass spectrometry,
and elemental analysis as well as by single-crystal X-ray diffrac-
tion analysis.
Scheme 1. Synthesis of nucleosides (S,R)-1 and (R,S)-1 and their methylated derivatives (S,R)-2 and (R,S)-2. Reagents and conditions: a) Yb(CF3SO3)3, ethylene
glycol, 110 8C, 30 min; b) hydroquinidine-2,5-diphenyl-4,6-pyrimidinediyl diether [(DHQD)2Pyr], K2OsO2(OH)4, K3Fe(CN)6, K2CO3, water/acetonitrile (1:1 v/v), ambi-
ent temperature, 3 h; c) hydroquinine 2,5-diphenyl-4,6-pyrimidinediyl diether [(DHQ)2Pyr] , K2OsO2(OH)4, K3Fe(CN)6, K2CO3, water/acetonitrile (1:1 v/v), ambient
temperature, 3 h; d) and e) NaH, DMF, ambient temperature, 2 h, then CH3I, ambient temperature, 20 h.
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X-ray diffraction study of enantiomers (S,R)-2 and (R,S)-2
The molecular structure of the nucleosides (S,R)-2 and (R,S)-2
in the solid state was determined by single-crystal X-ray diffrac-
tion analysis. Crystals suitable for these measurements were
grown from saturated DMSO solutions at ambient temperature
over 3 days. The molecular diagrams showing atom numbering
for (S,R)-2 and (R,S)-2 are shown in Figure 2. The crystallo-
graphic details are summarized in Table S1 in the Supporting
Information. The bond lengths and valence angles are sum-
marized in Tables S2–S7.
The methylated nucleosides (S,R)-2 and (R,S)-2 crystallize in
the chiral orthorhombic P212121 space group with one enantio-
mer of the respective compound in the asymmetric part of the
unit cell. The absolute configurations at the stereogenic cen-
ters C11 and C12 (Figure 2) were unambiguously assigned as
(S,R)-2 and (R,S)-2, respectively. The same absolute configura-
tion can be assigned for nonmethylated (S,R)-1 and (R,S)-1 nu-
cleosides. Alignment of molecules of (S,R)-2 and (R,S)-2 (after
digital inversion with the Mercury software) reveals that they
are almost isostructural with the root-mean-square deviation
(RMSD) of the atomic positions value equal to 0.0162 a. A su-
perimposed representation (after computed inversion) of the
enantiomers (S,R)-2 and (R,S)-2 is shown in Figure 3.
As well as the assignment of the absolute stereochemistry,
single-crystal X-ray diffraction analysis unambiguously con-
firmed that the thymine moiety is bonded to the carbon linker
through the N1 atom. The ferrocenyl moiety adopts an
eclipsed conformation with the average C1@Mp1@Mp2@C6
(Mp=midpoint of the cyclopentadienyl ligand) angles of
@1.138 and 0.818 for (S,R)-2 and (R,S)-2, respectively. The ge-
ometry of the methylated thymine does not show significant
differences compared with the literature.[34] In both structures
the methylated thymine moiety points away from the ferrocen-
yl group. The dihedral angles between the plane of the thy-
mine and substituted cyclopentadienyl ring in (S,R)-2 and (R,S)-
2 are 113.99(19)8 and 114.10(12)8, respectively. In the investi-
gated compounds, adjacent molecules are involved in weak
C@H···O hydrogen bonds, which results in the formation of the
complex supramolecular framework (Figure S9 and Tables S8
and S9).
UV/Vis absorption and CD spectroscopy and DFT calcula-
tions
The methylated nucleosides (S,R)-2 and (R,S)-2 were subjected
to UV/Vis absorption measurements in dichloromethane solu-
tion (Figure 4). The pattern of the absorption spectra is the
same for both compounds within the limit of error of the mea-
surement. The spectra show intense UV absorption bands
below 300 nm, a less intense near-UV band at 330 nm and rel-
atively weak absorptions in the visible region with the maxi-
mum at 438 nm (Table 1). Such a pattern of the absorption
spectra corroborates with the literature spectroscopic data for
ferrocene derivatives.[28d,40–45]
In order to get a more detailed insight into the nature of
the experimentally observed electronic transitions, calculations
Figure 2. The molecular diagram of (S,R)-2 (top) and (R,S)-2 (bottom) at the
50% probability level. Mp1 and Mp2 correspond to midpoints of the substi-
tuted and unsubstituted cyclopentadienyl ligands, respectively. Hydrogen
atoms have been omitted for clarity. Selected bond lengths [a] and
angles [8]: (S,R)-2/(R,S)-2 : Fe1@Mp1, 1.638(2)/1.639(2) ; Fe1@Mp2, 1.644(3)/
1.643(2) ; C1@C11, 1.497(6)/1.497(1) ; C11@C12, 1.541(6)/1.544(4) ; N1@C13,
1.464(6)/1.470(4) ; O1@C11, 1.431(6)/1.428(4) ; O2@C12, 1.422(6)/1.423(4); O1@
C18, 1.429(6)/1.424(4) ; O2@C19, 1.421(6)/1.422(4) ; N1@C17, 1.368(6)/1.374(4) ;
C1@C11@C12@C13, @53.6(5)/53.6(3); N1@C13@C2@C11, @171.9(4)/171.6(3).
Figure 3. An overlay of the enantiomers from the crystal structures of (S,R)-2
(blue) and (R,S)-2 (red); RMSD=0.0162 a; the molecule of (R,S)-2 is inverted.
Figure 4. UV/Vis absorption spectra of (S,R)-2 and (R,S)-2 in dichloromethane
solution normalized to 5.0V10@3 molL@1 at ambient temperature and the
TD-DFT-calculated electronic transitions for (R,S)-2 (vertical bars ; oscillator
strengths are given on the right y axis).
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were performed for (R,S)-2. The B3LYP/6-31G(d)/SDD level of
theory was used for geometry optimization, and the BPW91/6-
311G(d)/SDD level of theory was applied for time-dependent
density functional theory (TD-DFT) calculations. The optimized
geometry of (R,S)-2 is shown in Figure S10, the frontier molecu-
lar orbitals are depicted in Figure 5, and calculation details are
summarized in Tables S10 and S11.
As expected for the low-spin ferrocene derivative, the three
highest lying occupied molecular orbitals HOMO, HOMO-1 and
HOMO-2 in (R,S)-2 dominantly correspond to the iron-centered
dx2@y2 , dxy and dz2 atomic orbitals.
[40–45] The lowest unoccupied
molecular orbital (LUMO) of (R,S)-2 has p-character and is delo-
calized over the thymine moiety. The two higher lying LUMO+
1 and LUMO+2 molecular orbitals consist of iron-centered 3D-
orbitals with contribution of the cyclopentadienyl p orbitals.
The TD-DFT-calculated electronic absorption spectrum of (R,S)-
2 is shown in Figure 4. Only energies above 330 nm are consid-
ered as they refer to the experimentally measured CD spec-
trum in dichloromethane solution (Figure 6). The three calcu-
lated lowest energy transitions at 478.65, 478.29, and
472.89 nm agree with the position of the low-energy band ob-
served in the UV/Vis spectrum of (R,S)-2 at 438 nm. The first
calculated low-energy band at 478.65 nm predominantly con-
sists of HOMO to LUMO excitation, and can be assigned to a
metal-to-ligand charge-transfer electronic transition. The two
calculated bands centered at 478.29 and 472.89 nm include ad-
ditional transitions with d–d character, for example, HOMO-1
to LUMO+1 and HOMO to LUMO+2 orbitals. The three calcu-
lated bands at 423.06, 420.50, and 425.57 nm have a low oscil-
lator strength (f,0.0002). They can be assigned as iron-cen-
tered transitions with some contribution of a HOMO-2 to
LUMO transition. Finally, the calculated three highest energy
transitions at 343.24, 342.75, and 338.55 nm correspond to the
experimentally observed higher energy band at 330 nm. These
transitions involve the HOMO to LUMO+1, HOMO-2 to
LUMO+1 and HOMO-2 to LUMO+2 electronic transitions.
Overall, calculated vertical excitation energies are consistent
with the experimentally observed UV/Vis spectrum of (R,S)-2
and provide a detailed insight into the nature of all relevant
bands.
As described above, the absolute configurations of the
enantiomers of 2 in the solid state were established by X-ray
crystallography. With the following experiments, we aimed to
correlate the established stereochemistry of both enantiomers
with CD spectra in solution. CD spectra are excellent for estab-
lishing and predicting the absolute configurations for ferro-
cene derivatives.[46–48] Therefore, they can be used as guides for
the assignment of the absolute configuration of new ferrocenyl
nucleobases if X-ray crystal structures are not available. The CD
spectra of both enantiomers (S,R)-2 and (R,S)-2 are shown in
Figure 6. The (S,R)-2 enantiomer shows a weak positive Cotton
Table 1. UV/Vis absorption data of compounds (S,R)-2 and (R,S)-2.
Compound e [Lmol@1cm@1] lmax [nm]
(S,R)-2 123 438
88 330 (sh)
(R,S)-2 118 438
87 330 (sh)
Figure 5. Contour plots of selected Kohn–Sham frontier molecular orbitals
involved in calculated electronic transitions of (R,S)-2.
Figure 6. Baseline-corrected CD spectra of (S,R)-2 and (R,S)-2 in dichlorome-
thane normalized to 5.0V10@3 molL@1 at ambient temperature.
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effect in the d–d transition region between 310–370 nm and
an intense negative signal between 370–550 nm with a mini-
mum at approximately 480 nm. Conversely, an intense positive
signal is observed for the (R,S)-2 enantiomer between 370–
550 nm with a weak negative signal at 310–370 nm.
The CD spectra of the (S,R)-2 and (R,S)-2 compounds are
almost mirror images and can be used to determine the con-
figurations of similar compounds and derivatives.
Electrochemistry
Ferrocenyl XNA nucleotides have been utilized as building
blocks for construction of short redox-active nucleic acid
strands[35] and ferrocenyl guanine conjugates have been used
as standards for the quantification and analysis of DNA
strands.[49] Furthermore, it has been shown that specifically de-
signed, chelating oligonucleotides can self-assemble into
metal-mediated nanowire structures.[50] Keeping in mind the
predicted applications of ferrocenyl XNA nucleotides in biology
and material sciences, the electrochemical properties of (S,R)-1,
(R,S)-1, (S,R)-2 and (R,S)-2 were determined by cyclic voltamme-
try (CV) in dimethyl sulfoxide solutions containing weakly coor-
dinating [Bu4N][B(C6F5)4] (0.1 molL
@1) as a supporting electro-
lyte at room temperature. The CV measurements were record-
ed at scan rates varying between 50 and 200 mVs@1. All redox
potentials were referenced against the FcH/FcH+ redox couple
(E8’=0.00 V) as recommended by IUPAC [FcH=Fe(h5-C5H5)2] .
[51]
Table 2 shows the electrochemical data for the series of com-
pounds studied. Figures 7 and 8 show the voltammograms of
(S,R)-1 and (S,R)-2, whereas Figures S11 and S12 show the vol-
tammograms of (R,S)-1 and (R,S)-2.
All compounds undergo a single Nernstian one-electron fer-
rocenyl-centered redox process, which under the experimental
conditions applied occurs at E8’=@25 mV [(S,R)-1, (R,S)-1] or
75 mV [(S,R)-2), ((R,S)-2] against the standard redox couple
FcH/FcH+ . Compared to the nucleosides 1, the potential for
the ferrocenyl oxidation process of methyl derivatives 2 is
counterintuitively shifted anodically by 100 mV. It is notable
that the same anodic shift was reported for the FcNA2 nucleo-
side and its methylated derivative.[36] In order to explain these
unexpected results, DFT calculations were performed for (R,S)-1
and (R,S)-2 derivatives at the SMD-B3LYP/6-31G(d)//B3LYP/6-
31G(d)/SDD level of theory in dimethyl sulfoxide. The experi-
mental redox potentials of (R,S)-1 and its methylated analogue
(R,S)-2 were reproduced correctly by DFT calculations (Table 2
and Table S12). This might be surprising because the methoxy
group in (R,S)-2 is a stronger electron donor (has a positive in-
duction effect) than the hydroxy group in (R,S)-1. However, in
(R,S)-1 the a-hydroxy group is involved in the formation of a
strong intramolecular hydrogen bond to the neighboring b-hy-
droxy group (Figure S13). In the case of (R,S)-2 no such intra-
molecular interaction exists. It is likely that owing to the intra-
molecular hydrogen bond formation in (R,S)-1, the proton-do-
nating group (the a-OH group) increases its electron-donor
ability toward the ferrocenyl group, making it more readily oxi-
dized. This hypothesis was tested on ferrocenylmethanol (I in
Figure S14) and its methylated derivative (II in Figure S14).
Table 2. Voltammetric data for compounds (S,R)-1, (R,S)-1, (S,R)-2, and
(R,S)-2.
Compound Scan rate
[mVs@1]
E8’[a] (DEp)
[b]
[mV]
Ipa/Ipc
[c] Calcd E8’[d]
[mV]
(S,R)-1 50 @25 (68) 1.03 –
(R,S)-1 50 @25 (68) 1.08 @21.3
(S,R)-2 50 75(77) 1.08 –
(R,S)-2 50 75(65) 1.05 84.1
[a] E8’= formal potential. [b] DEp=potential difference between oxidation
and reduction. [c] Ipa/Ipc= ratio between anodic and cathodic peak cur-
rents. [d] Formal potential calculated at the SMD-B3LYP/6-31G(d)//B3LYP/
6-31G(d)/SDD level of theory in DMSO as a model solvent.
Figure 7. Cyclic voltammograms of dimethyl sulfoxide solutions containing
(S,R)-1 (1.0 mmol L@1) at 25 8C; supporting electrolyte: [N(nBu)4][B(C6F5)4]
(0.1 molL@1).
Figure 8. Cyclic voltammograms of dimethyl sulfoxide solutions containing
(S,R)-2 (1.0 mmol L@1) at 25 8C; supporting electrolyte: [N(nBu)4][B(C6F5)4]
(0.1 molL@1).
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These structures cannot take part in intramolecular hydrogen
bonding, and therefore the calculated redox potentials are
governed mainly by the inductive effects of the OH and OCH3
groups. As expected, the calculated redox potential of I is shift-
ed anodically by >10 mV compared to its methylated counter-
part II (Table S12). This is consistent with the electron-with-
drawing effect of the hydroxy group (negative induction
effect), which renders the Fe center more electron deficient,
and thus more difficult to oxidize. Therefore, we suggest that
the strong intramolecular hydrogen bonding in (R,S)-1 might
at least in part be responsible for the experimentally observed
redox potential. In summary, CV measurements confirmed that
the ferrocenyl nucleosides studied have desirable electrochem-
ical properties with respect to possible applications as redox-
active bioprobes or conducting nanowires.
Conclusions
A Sharpless asymmetric dihydroxylation reaction was applied
to obtain ferrocenyl GNA nucleosides. These are the first
known representatives of redox-active organometallic GNAs to
be reported and contribute to the expansion of the XNA
family. Furthermore, our synthetic design overcomes the prob-
lem of a challenging multistep synthesis, as was the case for
the planar chiral FcNA1 nucleoside. Both synthetic approaches,
ours and that reported for FcNA1 are complementary in the
sense that the former provides ferrocenyl GNA nucleosides
with defined central chirality and the latter enables planar
chiral molecules to be obtained.
The S,R and R,S absolute configuration of the chiral carbon
atoms in the Fc–GNA nucleosides was assigned by X-ray crys-
tallography of the methylated derivatives. Furthermore, CD
spectroscopy of both isomers was conducted. The CD spectra
are near-mirror images, reflecting the enantiomeric relationship
between the compounds. Electrochemical studies revealed
that each of the Fc–GNA nucleosides undergo reversible one-
electron oxidations at potentials of @25 mV (for nonmethylat-
ed derivatives) and 75 mV (for methylated derivatives). Further
synthetic, electrochemical and biological studies are needed to
probe the usefulness of the herein reported Fc–GNA nucleo-
sides as building blocks for oligonucleotide synthesis, as well
as to examine their electrochemistry and biological activity.
Experimental Section
General information
All preparations were performed using standard Schlenk tech-
niques. Chromatographic separations were performed using silica
gel 60 (Merck, 230–400 mesh ASTM) or aluminum oxide (EcoChrom
MP Biomedicals, Eschwege, Germany). DMF was distilled and
purged with argon prior to use. Other solvents were of reagent
grade and were used without prior purification. Thymine, 3-chloro-
propionyl chloride, sodium hydride, methyl iodide, ytterbium(III) tri-
fluoromethanesulfonate, potassium osmate(VI) dehydrate, hydro-
quinine 2,5-diphenyl-4,6-pyrimidinediyl diether [(DHQ)2Pyr], hydro-
quinidine-2,5-diphenyl-4,6-pyrimidinediyl diether [(DHQD)2Pyr] , and
potassium hexacyanoferrate(III) were purchased from commercial
suppliers and were used without further purification. 1H NMR
(600 MHz) and 13C{H} NMR (150 MHz) spectra were recorded with a
Bruker Avance III 600 spectrometer operating at 298 K in the Fouri-
er transform mode. Chemical shifts d are reported in ppm using re-
sidual DMSO as reference (1H d=2.50 ppm, 13C d=39.70 ppm).
Mass spectra were recorded using electron impact MS methods on
a Finnigan MAT 95 mass spectrometer. IR spectra were recorded on
a FTIR Nexus Nicolet instrument. Microanalyses were performed by
the Analytical Services of the Polish Academy of the Sciences
(Łjdz´). HPLC analyses were performed with a Shimadzu Promi-
nence system equipped with photodiode array detector and using
a Phenomenex Lux Cellulose-3 column 4.6V150 mm [for samples
of (S,R)-1 and (R,S)-1] or Lux Amylose-2 column 4.6V150 mm [for
samples of (S,R)-2 and (R,S)-2] . Detection was accomplished at l=
254 nm and a flow rate of 0.2 mLmin@1 was applied. The 1H and
13C NMR spectra of studied compounds are shown in Figures S1–S4
and S5–S8, respectively.
UV/Vis absorption and circular dichroism spectroscopy
UV/Vis absorption spectra were recorded in a 10 mm quartz cell
(Suprasil high-precision cell, Hellma GmbH, Mellheim, Germany)
within the 250–800 nm wavelength region using a Thermo Scientif-
ic Evolution 220 UV/Vis spectrophotometer. Circular dichroism
spectra were recorded in the wavelength range of 250–800 nm on
a Jasco J-815-150S spectropolarimeter, with 2 nm steps and a
dwell time of 2 s per step, using the same 10 mm quartz cell as de-
scribed above. The complexes were dissolved in dichloromethane
(&5V10@3 molL@1). The measured spectra were baseline-corrected
with the solvent spectrum. Camphorsulfonic acid served as a cali-
bration material for the CD instrument.
DFT calculations
All geometries were optimized at the B3LYP level of theory, as im-
plemented in the Gaussian09 software package.[52] The basis set
for optimization was standard Pople’s 6-31G(d) on nonmetal atom
centers, whereas the Stuttgart–Dresden (SDD)[53] basis set with ef-
fective core potential was used for Fe, similar to previous stud-
ies.[54] Harmonic frequencies were computed from analytical
second derivatives at the corresponding level of theory.
Implicit solvation effects were determined using the SMD continu-
um solvation model at the same B3LYP level, with the UFF atomic
radii and electrostatic scaling factor (alpha value) set to 1.1 for all
atoms (default values in Gaussian09).[55,56] The solvent relative per-
mittivity of e=8.93 (dichloromethane) was used. Formal redox po-
tentials were calculated at the B3LYP/6-31G(d)/SDD level of theory,
using the protocol scheme deposited in the Supporting Informa-
tion.
TD-DFT calculations were performed using Becke’s exchange func-
tional[57] and the Perdew–Wang correlation functional (BPW91).[58]
The basis set for the excitation energies calculation was the stan-
dard Pople’s 6-311G(d) on nonmetal atom centers, whereas the
SDD basis set was used for Fe. The lowest 20 singlet excited ener-
gies were calculated.
Electrochemistry
Electrochemical measurements on dichloromethane solutions of
(S,R)-1, (R,S)-1, (S,R)-2, and (R,S)-2 (1.0 mmolL@1) were performed at
25 8C with a Radiometer Voltalab PGZ 100 electrochemical worksta-
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tion interfaced with a personal computer. Dimethyl sulfoxide
(0.1 molL@1) containing [NBu4][B(C6F5)4]
[59] was used as supporting
electrolyte. For the measurements a three-electrode cell was used
containing a Pt auxiliary electrode, a glassy carbon working elec-
trode (surface area 0.031 cm2) and a Ag/Ag+ (AgNO3,
0.01 mmolL@1) reference electrode fixed on a Luggin capillary. The
working electrode was pretreated by polishing on a Buehler micro-
cloth first with a 1 mm and then a 0.25 mm diamond paste. The ref-
erence electrode was constructed as previously described.[60] Ex-
periments under the same conditions showed that all reduction
and oxidation potentials were reproducible within 5 mV. Experi-
mental potentials were referenced against a Ag/Ag+ reference
electrode, but the presented results are referenced against ferro-
cene as an internal standard, as required by IUPAC.[51] To achieve
this, each experiment was repeated in the presence of decamethyl-
ferrocene (Fc*, 1 mmolL@1). Data were processed on a Microsoft
Excel worksheet to set the formal reduction potentials of the FcH/
FcH+ couple to 0.0 V. Under our conditions, the Fc*/Fc*+ couple
was at @469 mV versus FcH/FcH+ (DEp=60 mV).
Synthesis of thymine olefin B
Ytterbium(III) trifluoromethanesulfonate (19 mg, 0.03 mmol) was
added in a single portion to a stirred solution of thymine alcohol A
(110 mg, 0.30 mmol) in ethylene glycol (60 mL) at ambient temper-
ature. The resulting reaction mixture was stirred at 110 8C for 20 h.
After cooling to ambient temperature, the reaction was quenched
with water (10 mL) and the obtained mixture was extracted with
chloroform. The organic layer was separated in a separating
funnel, dried over anhydrous MgSO4, filtered through a Schott
funnel and then all volatile materials were evaporated. The residue
was subjected to column chromatography on SiO2 (dichlorome-
thane/methanol, 50:1 v/v). Crystallization from dichloromethane/n-
hexane gave the pure B as orange-yellow crystals (69 mg, 66%
yield). For spectral data, see Ref. [37].
General procedure for the synthesis of nucleosides (S,R)-1
and (R,S)-1
The thymine olefin B (105 mg, 0.30 mmol), (DHQ)2Pyr or
(DHQD)2Pyr (26 mg, 0.03 mmol), potassium osmate(VI) dehydrate
(4 mg, 0.01 mmol), potassium hexacyanoferrate(III) (296 mg,
0.90 mmol), K2CO3 (124 mg, 0.90 mmol) and a water/acetonitrile
(1:1 v/v) mixture was placed in a Schlenk flask. The reaction mix-
ture was stirred at ambient temperature for 3 h. Then,
Na2SO3·7H2O (681 mg, 2.70 mmol) was added in a single portion
and the reaction mixture was stirred for 20 min, Then it was ex-
tracted with chloroform. The organic layer was separated in a sepa-
rating funnel, dried over anhydrous MgSO4, filtered through a
Schott funnel and then all volatile materials were evaporated
under reduced pressure. The residue was subjected to column
chromatography on SiO2 (dichloromethane/methanol, 50:1 v/v).
Chromatographically purified nucleosides (S,R)-1 and (R,S)-1 were
crystallized from a mixture of dichloromethane/methanol/n-hep-
tane to afford analytically pure samples. Isomer (S,R)-1 was ob-
tained as a yellow crystalline solid (83 mg, 72% yield); ee>99% by
HPLC (t=20.27 min). Isomer (R,S)-1 was obtained as a yellow crys-
talline solid (80 mg, 70% yield); ee=71% by HPLC (t=19.44 min).
1: 1H NMR (600 MHz, [D6]DMSO): d=11.14 (s, 1H; NH), 7.33(s, 1H;
thymine), 4.81(d, JH,H=6.0 Hz, 1H; OH), 4.79 (d, JH,H=6.6 Hz, 1H;
OH), 4.29 (br s, 2H; C5H4), 4.26 (br s, 1H; CH), 4.15 (s, 5H; C5H5), 4.08
(br s, 2H; C5H4), 3.88–3.82 (m, 2H; CH and 1H CH2), 3.30 (s; H2O
overlapped with 1H CH2), 1.73 ppm (s, 3H; thymine CH3) ;
13C{1H} NMR (150 MHz, [D6]DMSO): d=164.5, 151.2, 143.0, 107.4,
90.0, 71.5, 70.2, 68.5, 67.4, 67.3, 67.2, 67.0, 51.3, 12.0 ppm; FTIR
(KBr): n˜=3351, 3167, 3056, 2955, 2920, 1698, 1673, 1474,
1369 cm@1; MS (EI): m/z : 384 [M]+ , 366 [M@H2O]+ ; elemental analy-
sis calcd (%) for C18H20N2O4Fe: C 56.27, H 5.25, N 7.29; found: (S,R)-
1: C 56.39, H 5.51, N 7.24; (R,S)-1: C 56.31, H 5.19, N 7.26.
General procedure for the synthesis of methylated nucleo-
sides (S,R)-2 and (R,S)-2
Sodium hydride (22 mg, 0.90 mmol) was added in a single portion
to a stirred solution of either (S,R)-1 or (R,S)-1 (115 mg, 0.30 mmol)
in anhydrous DMF (30 mL). After stirring the reaction mixture for
2 h, CH3I (128 mg, 0.90 mmol, 56 mL) was added in a single portion
and the reaction mixture was stirred at ambient temperature for
20 h. Subsequently, water (&10 mL) was added and the reaction
mixture was extracted with chloroform. The organic layer was sep-
arated in a separating funnel, dried over anhydrous MgSO4, filtered
through a Schott funnel and all volatiles were evaporated under
reduced pressure. The remaining solid was subjected to column
chromatography on deactivated Al2O3 (Al2O3/H2O, 30/1.25 g) with
diethyl ether as eluent. Crystallization from a dichloromethane/n-
pentane mixture gave analytically pure samples. Isomer (S,R)-2 was
obtained as a yellow crystalline solid (42 mg, 33% yield); ee>99%
by HPLC (t=12.68 min). Isomer (R,S)-2 was obtained as a yellow
crystalline solid (43 mg, 34% yield); ee 90% by HPLC (t=
12.27 min).
2 : 1H NMR (600 MHz, [D6]DMSO): d=7.36 (s, 1H; thymine), 4.25
(br s, 1H; C5H4), 4.21 (br s, 1H; C5H4), 4.17 (s, 7H; C5H5 and C5H4),
4.16 (d, JH,H=3.6 Hz, 1H; Fc-CHOMe), 3.92 (dd, JH,H=13.8, 3.6 Hz,
1H; CH2), 3.76 (dt, JH,H=8.4, 3.6 Hz, 1H; Fc-CH(OMe)CHOMe), 3.46
(s, 3H; CH3), 3.34 (dd, JH,H=13.8, 8.4 Hz, 1H; CH2), 3.27 (s, 3H; CH3),
3.18 (s, 3H; CH3), 1.79 ppm (s, 3H; CH3) ;
13C{1H} NMR (150 MHz,
[D6]DMSO): d=163.5, 151.2, 140.9, 107.0, 85.7, 80.2, 78.0, 68.7, 67.8,
67.4, 67.1, 67.0, 58.4, 57.8, 49.9, 27.6, 12.6 ppm; FTIR (KBr): n˜=
3090, 2978, 2933, 2827, 1698, 1666, 1640, 1468, 1368 cm@1; EI-MS
(EI): m/z : 426 [M]+ ; elemental analysis calcd (%) for C21H26N2O4Fe: C
59.17, H 6.15, N 6.57; found: (S,R)-2 : C 59.20, H 6.31, N 6.42; (R,S)-2 :
C 59.42, H 6.31, N 6.20.
X-ray data collection and refinement of data
Good-quality single crystals of (S,R)-2 and (R,S)-2 were selected for
the X-ray diffraction experiments at T=100(2) K. Diffraction data
were collected on the Agilent Technologies SuperNova Dual
Source diffractometer with CuKa radiation (l=1.54184 a) using
CrysAlis RED software.[61] In all cases the analytical numerical ab-
sorption correction using a multifaceted crystal model based on
expressions derived by Clark and Reid[62] and implemented in the
SCALE3 ABSPACK scaling algorithm was applied.[61] The structural
determination procedure was carried out using the SHELX pack-
age.[63] The structures were solved with direct methods and then
successive least-square refinement was carried out based on the
full-matrix least-squares method on F2 using the XLMP program.[63]
All H atoms were positioned geometrically, with C@H equal to 0.93,
0.96, 0.97 and 0.98 a for the aromatic, methyl, methylene and me-
thine H atoms, respectively, and constrained to ride on their parent
atoms with Uiso(H)=xUeq(C), where x=1.2 for the aromatic, methyl-
ene and methine H atoms, and x=1.5 for the methyl H atoms. The
figures for this publication were prepared using Olex2, Mercury
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and ORTEP-3 programs.[64–66] The molecular interactions were iden-
tified using PLATON.[67]
CCDC 1585503 and 1585502 contain the supplementary crystallo-
graphic data for this paper. These data are provided free of charge
by The Cambridge Crystallographic Data Centre.
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